^
    Apply
    Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE) (NCT03658967)
    Phase 2
    Herantis Pharma Plc.
    Active, not recruiting
    Last update posted :
    10/19/2023
    Initiation :
    06/07/2018
    Primary completion :
    12/16/2019
    Completion :
    12/31/2024
    VEGFC
    |
    Lymfactin (adAptVEGF-C adenoviral vector)